West Pharmaceutical Services WST Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: West Pharmaceutical Services’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's financing cash flow?
- West Pharmaceutical Services (WST) reported financing cash flow of -$164.8M in Q2 2026.
- How has West Pharmaceutical Services's financing cash flow changed year-over-year?
- West Pharmaceutical Services's financing cash flow decreased by 1006.0% year-over-year, from -$14.9M to -$164.8M.
- What is the long-term trend for West Pharmaceutical Services's financing cash flow?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's financing cash flow has grown at a 2.4% compound annual growth rate (CAGR), from -$168.4M to -$185.1M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.